Vimian Group
30.10 SEK
-0.99 %
Less than 1K followers
VIMIAN
NASDAQ Stockholm
Health Care Providers
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Vimian Group
P/E
Median 2021-2025
EV/S
Median 2021-2022
EV/EBIT
Median 2021-2022
P/B
Median 2021-2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share price (SEK) | 76.83 | 26.36 | 28.66 | 39.80 | 30.34 |
| Shares | 324.1 | 454.5 | 472.1 | 523.9 | 529.3 |
| Market cap | 24,903.0 | 11,978.5 | 13,530.7 | 20,850.9 | 16,057.8 |
| Enterprise value | 26,186.9 | 13,831.9 | - | - | - |
| EV/S | 14.7 | 4.4 | - | - | - |
| EV/EBITDA | 66.7 | 18.6 | - | - | - |
| EV/EBIT | 118.3 | 31.5 | - | - | - |
| P/E | 369.0 | neg. | 132.9 | 86.8 | 46.8 |
| P/B | 6.77 | 2.23 | 2.31 | 2.57 | 2.10 |
| P/S | 14.0 | 3.8 | 3.7 | 4.9 | 3.5 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 56.0 % | 52.2 % | 54.1 % | 63.7 % | 63.9 % |
| Gearing ratio | 50.3 % | 43.0 % | 59.6 % | 33.1 % | 33.7 % |